Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA. (May 2023) - Quang, V. Tran; Podvin, B.; Desterke, C.; Tarfi, S.; Barathon, Q.; Bouchra, B.; Freynet, N.; Parinet, V.; Leclerc, M.; Sébastien, M.; Solary, E.; Selimoglu-Buet, D.; et al.